Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model

Journal of Molecular Histology

Volumn 38, Issue 5, 2007, Pages 425-433

  Woodruff, Maria Ann ^a   Rath, Subha Narayan ^a   Susanto, Evelyn ^a   Haupt, Larisa M ^b   Hutmacher, Dietmar W ^a,c   Nurcombe, Victor ^b,c   Cool, Simon M ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomaterials; Bone regeneration; CT scanning; Glycosaminoglycans

Indexed keywords

ALKALINE PHOSPHATASE; BIOMATERIAL; FIBRIN GLUE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HYDROGEL; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SKULL DEFECT; WOUND HEALING;

ALKALINE PHOSPHATASE; ANIMALS; BONE REGENERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FIBRIN TISSUE ADHESIVE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; OSTEOGENESIS; PARIETAL BONE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED; WOUND HEALING;

RATTUS;

EID: 35848949104     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9137-y     Document Type: Article

References (37)

1. Babensee JE, McIntyre LV, Mikos AG (2000) Growth factor delivery for tissue engineering. Pharm Res 17:497-504
2. Blanquaert F, Saffar JL, Colombier ML, Carpentier G, Barritault D, Caruelle JP (1995) Heparan-like molecules induce the repair of skull defects. Bone 17:499-506
3. Choi KY, Kim HJ, Lee MH, Kwon TG, Nah HD, Furuichi T, Komori T, Nam SH, Kim YJ, Kim HJ, Ryoo HM (2005) Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 233(1):115-121
4. Cool SM, Nurcombe V (2005) The osteoblast-heparan sulfate axis: control of the bone cell lineage. Int J BiochemCell Biol 37(9):1739-1745
5. Coombe DR, Kett WC (2005) Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci 62:410-424
6. DeBlois C, Cote MF, Doillon CJ (1994) Heparin-fibroblast growth factor fibrin complex: in vitro and in vivo applications to collagen based materials. Biomaterials 15(9):665-672
7. Depprich R, Handschel J, Sebald W, Kubler NR, Wurzler KK (2005) Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants. Mund Kiefer Gesichtschir 9:363-368
8. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13(8):1025-1036
9. Fakhry A (2005) Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36:254-266
10. Guido D, Bernfield M (1998) The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol 17(7):461-463
11. Irie A, Habuchi H, Kimata K, Sanai Y (2003) Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun 308:858-865
12. Jackson RA, McDonald MM, Nurcombe V, Little DG, Cool SM (2006a) The use of heparan sulfate to augment fracture repair in a rat fracture model. J Orthop Res 24:636-644
13. Jackson RA, Nurcombe V, Cool SM (2006b) Coordinated fibroblast growth factor and heparan sulfate regulation of Osteogenesis. Gene 379:79-91
14. Kasai S, Kunimoto T, Nitta K (1983) Cross linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed Res 4:155-160
15. Keller J, Anderasses TT, Joyce F (1985) Fixation of osteochondral fractures: fibrin sealant tested in dogs. Acta Orthop Scand 56:323-326
16. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755-764
17. Lafont J, Blanquaert F, Colombier ML, Barritault D, Carueelle JP, Saffar JL (2004) Kinetic study of early regenerative effects of RGTA11, a heparan sulfate mimetic, in rat craniotomy defects. Calcif Tissue Int 75:517-525
18. Le Nihouannen D, Le Guehennen L, Rouillon T, Pilet P, Bilban M, Layrolle P, Daculsi G (2006) Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 27:2716-2722
19. Luong-Van E, Grøndahl L, Nurcombe V, Cool SM (2007) In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 28:2127-2136
20. Lyon M, Gallagher JT (1998) Bio-specific sequences and domains in heparan sulfate and the regulation of cell growth and adhesion. Matrix Biol 17(7):485-493
21. Marktl W, Rudas B (1974) The effect of factor XIII on wound granulation in the rat. Thromb Diath Haemorrh 32:578-581
22. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89(5):773-779
23. Ng KW, Spiecher T, Dombrowski C, Helledie T, Haupt LM, Nurcombe V, Cool SM (2007) Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 16:305-318
24. Ornitz DM, Marie PJ (2002) FGF signaling pathways in endochondral and intra-membranous bone development and human genetic disease. Genes Dev 16:1446-1465
25. Osmond RI, Kett WC, Skett SE, Coombe DR (2002) Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. Anal Biochem 310:199-207
26. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89(5):765-771
27. Pandit AS, Wilson DJ, Feldman DS (2000) Fibrin scaffold as an effective vehicle for the delivery of acidic growth factor (FGF-1). J Biomater Appl 14(3):229-242
28. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi JY, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ (2003) Cell growth regulatory cell regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63(17):5357-5362
29. Rai B, Teoh SH, Hutmacher DW, Cao T, Ho KH (2005) Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 26:3739-3748
30. Ruppert R, Hoffmann E, Sebald W (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237:295-302
31. Saksela O, Rifkin D (1989). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. Fibrinolysis 3:36
32. Shao XX, Hutmacher DW, Ho ST, Goh JC, Lee EH (2006) Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials 27(7):1071-1080
33. Shireman PK, Greisler HP (1998) Fibrin Sealant in vascular surgery: a review. J Long Term Eff Med Implants 8:117-132
34. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R (2003) Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229-43235
35. Turnbull J, Powell A, Guimond S (2001). Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11(2):75-82
36. Vasita R, Katti DS (2006) Growth factor delivery systems for tissue engineering: a materials perspective. Expert Rev Med Devices 3(1):29-47
37. Zhang X, Sobue T, Hurley MM (2002) FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun 290:526-531